Our bodies are wired to defend themselves against foreign invaders. After a patient undergoes an organ transplant, the body responds to the new organ as if it were a foreign object. The immune system goes into overdrive trying to reject it. This is why it is vital for transplant patients to take anti-rejection medications or immunosuppressant drugs immediately following transplant surgery and for the rest of their lives.
Life on Anti-Rejection Medications After Transplant
Potential Side Effects of Anti-Rejection Medication After Transplant
While necessary to keep transplant patients alive, anti-rejection medications do come with a few potential side effects. This is especially true of the drug tacrolimus, which is one of the most common anti-rejection medications available. Because this medication suppresses the immune system, the patient has a higher risk of infections and infectious complications. The drug can also cause high blood pressure and gout, have adverse effects on kidney function, and potentially create blood cell issues.
The side effects of anti-rejection medications may feel overwhelming at first. That’s why we closely monitor our post-transplant patients throughout their life and provide intense post-op care.” - Dr. Ram Subramanian
The Importance of Proper Follow-Up Care
After a transplant, patients will need to follow up with their medical team regularly, especially during the months following the transplant.
“In the first few months, we see patients almost every week,” notes Subramanian. “In the first month after the transplant, we get labs and run blood tests up to three times a week. As time goes on, we allow more time between follow-ups, but we never really stop monitoring these patients.”
Your physician will also let you know which other drugs could interact poorly with your medication and alert you to any necessary lifestyle changes. For instance, grapefruit juice affects the body’s absorption of anti-rejection medications and should be avoided. And, because these life-saving organs require extra care, medical professionals will insist patients abstain from alcohol after a liver transplant.
Medication Education
Since patients must start taking pharmaceuticals on a daily basis, there’s an education process that occurs immediately after their transplant.
“Before discharging a patient, our team sits down with him and his family to review the medications. Everyone needs to know what the medicine looks like, the frequency at which it should be taken, as well as what time of day,” explains Subramanian. “It’s very detailed training for the patient and his family.”
It’s absolutely vital patients don’t skip any days of their medication or stop taking it, even if they appear to be in good health. Without the medication, the body can still reject the organ at any time, and the signs of rejection are very subtle.
Living a Long Life on Anti-Rejection Medications
If patients take care of themselves and are compliant with their anti-rejection medications, they can have a long life after organ transplant.
“I recently saw someone in the clinic who does an excellent job taking his medicine and caring for his body,” notes Subramanian. “His liver transplant took place 30 years ago and he’s still here thanks to his anti-rejection medication.”
For more information about organ transplant and the Emory Transplant Center, visit emoryhealthcare.org/transplant.
Dr. Subramanian
Dr. Ram Subramanian is Associate Professor of Medicine and Surgery, and the Medical Director of Liver Transplantation. In his dual role as a transplant hepatologist and an intensivist.
Dr. Subramanian is involved in the inpatient care of patients before and after liver transplantation. His clinical and research interests are focused on critical care issues related to hepatic failure and liver transplantation.
Related Posts
-
Using Lean methodology, Emory Transplant Center identifies quality issues and finds effective solutions to improve patient care. Learn more.
-
Emory Transplant Center performs first-ever triple organ transplant procedure in Georgia, involving the transplantation of a heart, liver and kidney.
-
The RaDIANT Study at Emory Transplant Center collects regional and national data to help understand disparities in the kidney transplant process.
Recent Posts
-
Dec 13, 2024
-
Dec 10, 2024
-
Dec 5, 2024
-
Dec 3, 2024
-
Emory in the News: Experts Address Early Onset Cancer, AI Use in Health Care, Dementia Care and MoreNov 26, 2024
-
Nov 19, 2024